Biotechnology APAC News & Press Release Distribution

Biotechnology

All
Global

BOI Says Investors Show Increasing Interest in Thailand's Medical Sector

BANGKOK, Sept. 2, 2020 /PRNewswire/ -- A growing number of international and Thai companies are investing inThailand's medical to help address the COVID-19 situation as well as to build on the country's potential as a medical hub, the Thailand's Board of Investment (BOI) said.

2020-09-02 17:35 4770

BOI Says Investors Show Increasing Interest in Thailand's Medical Sector

Humoral immune response to SARS-CoV2 in Iceland

Titers of antibodies against SARS-CoV2 do not decline within four months REYKJAVIK, Iceland, Sept. 2, 2020 /PRNewswire/ -- Scientists at deCODE genetics inIceland, a subsidiary of Amgen Inc , biopharmaceutical company headquartered inCalifornia, and their collaborators, today publish a study in ...

2020-09-02 05:00 3562

Ortho Announces Board of Director Appointments

Noted Diagnostic Industry Veteran David B. Perez Joins as an Independent Director Chris Smith Appointed Chairman of the Board, in addition to current CEO role RARITAN, N.J., Sept. 2, 2020 /PRNewswire/ -- Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, today announced thatDav...

2020-09-02 04:51 2229

Bridgewest Australia Holdings LLC Acquires Pfizer manufacturing facility in Adelaide, Australia

Bridgewest to develop the site into a full-service Contract Development and Manufacturing Organization SAN DIEGO and ADELAIDE, Australia, Sept. 2, 2020 /PRNewswire/ -- The Bridgewest Group, a premier private investment company that focuses on disrupting industries through innovation today announ...

2020-09-02 01:01 5210

Aqua Medical Announces Final $8.2 Million Equity Investment Led by ShangBay Capital to Close Its $15.5 Million Series A Financing Round

Investment will be used to advance its novel vapor-based ablation system to treat precancerous conditions and metabolic disease such as type 2 diabetes in the gastrointestinal (GI) tract. SANTA ANA, California, Sept. 1, 2020 /PRNewswire/ -- Aqua Medical's innovative platform technology provides ...

2020-09-01 22:00 2532

Visiopharm raises fresh capital with BankInvest as lead investor

COPENHAGEN, Denmark, Sept. 1, 2020 /PRNewswire/ -- In a new investment round, Visiopharm added BankInvest to the group of institutional investors that already includes ATP, NorthCap, Vækstfonden, and C.L. Davids Fond. BankInvest now holds almost 6% of the equity of the company. All existing inves...

2020-09-01 14:00 2103

GEN inCode Announces Completion of £3M Institutional Foundation Fundraise

OXFORD, England, Sept. 1, 2020 /PRNewswire/ -- GEN inCode UK Limited, the privately-owned artificial intelligence cardiovascular disease company focused on the prevention of cardiovascular disease, announces today the completion of a £3.0M institutional fundraise to internationally scale its prod...

2020-09-01 14:00 2245

GenScript Biotech Corporation signs exclusive agreement with PH biotech firm to distribute faster, more accurate and more affordable immunity tests for COVID-19

SINGAPORE, Sept. 1, 2020 /PRNewswire/ -- GenScript Biotech Corporation ("GenScript", Stock Code: 1548.HK) entered an exclusive partnership with Philippines biotech company, IP Biotech. ). This will allow the firm to distribute a breakthrough test kit designed to measure the levels of neutralizing...

2020-09-01 10:30 10596

Cedrus Group's Chairman Mr. Rani Jarkas Invited to Speak at the ANNUAL BIOPHARMA DEVELOPMENT AND PRODUCTION WEEK

HONG KONG, Sept. 1, 2020 /PRNewswire/ -- The Chairman of Cedrus Group ("Cedrus") , Mr. Rani Jarkas, is invited to speak at the"6th Annual Biopharma Development and Production Week" conference to be held on 3rd - 5th November 2020. This year, the event will be ...

2020-09-01 09:00 5086

Viva Biotech Announced 2020 Interim Results

Financial Highlights for the 6 months ended June 30, 2020 * Revenue amounted to RMB197.6 million, representing a YOY increase of 38.9% * Gross profit amounted to RMB100.1 million, representing a YOY increase of 39.2%, with Gross profit margin of 50.7% * Adjusted net profit rose to RMB123.7 m...

2020-08-31 23:27 7346

Viva Biotech Announced 2020 Interim Results

GenScript Reports 2020 Interim Results and Provides Business Update

NANJING, China, Aug. 31, 2020 /PRNewswire/ -- GenScript Biotech Corp. (Stock Code: 1548.HK), a leading global biotechnology company, today reported interim results for the six months endedJune 30, 2020 and provided a corporate update. Revenue of the Group for the six months endedJune 30, 2020 was...

2020-08-31 11:32 11922

Innovent Announces the Results of the Phase 1/2 Clinical Study of PCSK9 Antibody Tafolecimab at the European Society of Cardiology Annual Conference

SAN FRANCISCO and SUZHOU, China, Aug. 31, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent" or "the Company") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune a...

2020-08-31 08:00 5884

G-ray Switzerland announces new CEO, closes successful funding round

NEUCHÂTEL, Switzerland, Aug. 31, 2020 /PRNewswire/ -- G-ray Switzerland, the medical imaging and industrial diagnosis start-up founded in 2014, has announced the appointment of Luis Pallares as Chief Executive Officer, as the company embarks on an accelerated growth drive and completes a successf...

2020-08-31 06:00 4032

Million-selling Erba COVID-19 antibody tests now validated on leading ELISA analysers

LONDON, Aug. 31, 2020 /PRNewswire/ -- To improve global availability of high-quality testing methods for SARS-CoV-2,Erba Mannheim announced the availability of validated automated protocols for their successful range of ErbaLisa COVID-19 IgG and IgM ELISA kits. Optimised protocols for popular ins...

2020-08-31 06:00 3397

Changsha Haike, a HYCOR Biomedical Partner, Announces Registration From China HMPA for the ALLEOS™ 2000 System

GARDEN GROVE, California, Aug. 29, 2020 /PRNewswire/ -- HYCOR Biomedical, a leading manufacturer ofin vitro diagnostic products for allergy testing, and Changsha Haike Biotechnology Co., Ltd., its Chinese manufacturing partner, announced registration from Hunan Medical Products Administration ...

2020-08-29 05:03 6565

Sirtex Medical and China Grand Pharmaceutical announce landmark drug registration milestone

Approval issued to file new drug application for SIR-Spheres® Y-90 resin microspheres inChina based on existing clinical trial data. WOBURN, Mass., Aug. 27, 2020 /PRNewswire/ -- Sirtex Medical ("Sirtex"), a leading manufacturer of targeted liver cancer therapies, announced today that Sirtex and ...

2020-08-27 20:30 3738

Enrolment initiated in World's First RCT with Sirolimus Coated Balloon for the treatment of Below-the-Knee (BTK) Peripheral Artery Disease

SINGAPORE, Aug. 27, 2020 /PRNewswire/ -- Concept Medical Inc ., focused on vascular intervention drug delivery devices, has announced the enrolment of the first patient in theFUTURE BTK trial (Randomized Controlled Trial of First SirolimUs CoaTed Balloon VersUs S...

2020-08-27 18:16 4252

Enrolment initiated in World's First RCT with Sirolimus Coated Balloon for the treatment of Below-the-Knee (BTK) Peripheral Artery Disease

Ascentage Pharma Releases Preclinical Results of IAP Antagonist APG-1387 in an Oral Presentation at EASL ILC 2020

SUZHOU, China and ROCKVILLE, Md., Aug. 27, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that preclinical study resul...

2020-08-27 18:10 5197

How the Dutch resume elective surgery in melanoma after COVID delays

ROTTERDAM, Netherlands and SAN DIEGO, Aug. 26, 2020 /PRNewswire/ -- SkylineDx signed a collaboration agreement with a multi-disciplinary clinical consortium inthe Netherlands that designed a trial to implement a diagnostic innovation to manage continuity of care delivery when resources are under ...

2020-08-26 21:06 3050

DiscGenics Raises $50 Million in Series C Funding

SALT LAKE CITY, Aug. 26, 2020 /PRNewswire/ -- DiscGenics, Inc., a clinical stage biopharmaceutical company developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative diseases of the spine, today announced it has raised$50 million in a Serie...

2020-08-26 08:30 3292

1 ... 161 162 163164165 166 167 ... 180